{"id":85011,"date":"2023-11-01T18:41:02","date_gmt":"2023-11-01T13:11:02","guid":{"rendered":"http:\/\/finservwealth.com\/maitreya-medicare-ipo-subscribed-410-times-on-final-day\/"},"modified":"2023-11-01T18:41:02","modified_gmt":"2023-11-01T13:11:02","slug":"maitreya-medicare-ipo-subscribed-410-times-on-final-day","status":"publish","type":"post","link":"https:\/\/finservwealth.com\/hi\/maitreya-medicare-ipo-subscribed-410-times-on-final-day\/","title":{"rendered":"Maitreya Medicare IPO subscribed 410 times on final day"},"content":{"rendered":"<p> Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said.<\/p><div id=\"finse-261703105\" class=\"finse-content finse-entity-placement\"><script async src=\"\/\/pagead2.googlesyndication.com\/pagead\/js\/adsbygoogle.js?client=ca-pub-9118214110898834\" crossorigin=\"anonymous\"><\/script><ins class=\"adsbygoogle\" style=\"display:block;\" data-ad-client=\"ca-pub-9118214110898834\" \ndata-ad-slot=\"\" \ndata-ad-format=\"auto\"><\/ins>\n<script> \n(adsbygoogle = window.adsbygoogle || []).push({}); \n<\/script>\n<\/div>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/maitreya-medicare-ipo-subscribed-410-timesfinal-day_17295051.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said. Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/maitreya-medicare-ipo-subscribed-410-timesfinal-day_17295051.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>","protected":false},"excerpt":{"rendered":"<p><!-- wp:html --><\/p>\n<p> Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said.<\/p>\n<p><a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/maitreya-medicare-ipo-subscribed-410-timesfinal-day_17295051.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a><\/p>\n<p>\u200b\u00a0Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said. Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said.\u00a0\u00a0Moneycontrol Latest News\u00a0<a href=\"https:\/\/www.moneycontrol.com\/news\/ipo-news\/maitreya-medicare-ipo-subscribed-410-timesfinal-day_17295051.html\" target=\"_blank\" class=\"feedzy-rss-link-icon\" rel=\"noopener\">Read More<\/a>\u00a0\u00a0<\/p>\n<p><!-- \/wp:html --> Given the overwhelming response to the issue, investors in the grey market looked optimistic as IPO shares continued to trade with 73 percent premium over the upper price band, analysts said.<\/p>","protected":false},"author":0,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"content-type":"","_monsterinsights_skip_tracking":false,"_monsterinsights_sitenote_active":false,"_monsterinsights_sitenote_note":"","_monsterinsights_sitenote_category":0,"neve_meta_sidebar":"","neve_meta_container":"","neve_meta_enable_content_width":"","neve_meta_content_width":0,"neve_meta_title_alignment":"","neve_meta_author_avatar":"","neve_post_elements_order":"","neve_meta_disable_header":"","neve_meta_disable_footer":"","neve_meta_disable_title":"","_themeisle_gutenberg_block_has_review":false,"footnotes":""},"categories":[70],"tags":[],"class_list":["post-85011","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-latest-news"],"jetpack_featured_media_url":"https:\/\/www.moneycontrol.com\/news_image_files\/2023\/200x200\/M\/Maitreya_Medicare_200.jpg","_links":{"self":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/85011","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/comments?post=85011"}],"version-history":[{"count":0,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/posts\/85011\/revisions"}],"wp:attachment":[{"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/media?parent=85011"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/categories?post=85011"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/finservwealth.com\/hi\/wp-json\/wp\/v2\/tags?post=85011"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}